Guard Therapeutics International AB (OSTO:GUARD) Cyclically Adjusted Book per Share: kr70.78 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:GUARD Guard Therapeutics International AB OSTO:GUARD
25 GF Score
Price kr1.58
! 1 Warning Sign
View Full Analysis

What is Guard Therapeutics International AB Cyclically Adjusted Book per Share?

Guard Therapeutics International AB OSTO:GUARD +1.15% 25 Cyclically Adjusted Book per Share is kr70.78 as of Mar. 2026. GuruFocus rates OSTO:GUARD with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Guard Therapeutics International AB's adjusted book value per share for the three months ended in Mar. 2026 was kr1.812. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr70.78 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Guard Therapeutics International AB's average Cyclically Adjusted Book Growth Rate was -46.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -34.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Guard Therapeutics International AB was -19.20% per year. The lowest was -34.00% per year. And the median was -26.60% per year.

As of today (2026-07-14), Guard Therapeutics International AB's current stock price is kr1.578. Guard Therapeutics International AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr70.78. Guard Therapeutics International AB's Cyclically Adjusted PB Ratio of today is 0.02.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Guard Therapeutics International AB was 0.02. The lowest was 0.00. And the median was 0.00.


Guard Therapeutics International AB  (OSTO:GUARD) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Guard Therapeutics International AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.578/70.78
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Guard Therapeutics International AB was 0.02. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Guard Therapeutics International AB Cyclically Adjusted Book per Share Related Terms


Guard Therapeutics International AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Guard Therapeutics International AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guard Therapeutics International AB Cyclically Adjusted Book per Share Chart

Guard Therapeutics International AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 294.99 291.81 237.14 155.56 84.01

Guard Therapeutics International AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 131.40 114.81 99.98 84.01 70.78

OSTO:GUARD vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Guard Therapeutics International AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guard Therapeutics International AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guard Therapeutics International AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Guard Therapeutics International AB's Cyclically Adjusted PB Ratio falls into.


OSTO:GUARD
25GF Score
Guard Therapeutics International AB OSTO:GUARD
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guard Therapeutics International AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guard Therapeutics International AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.812/133.5600*133.5600
=1.812

Current CPI (Mar. 2026) = 133.5600.

Guard Therapeutics International AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 534.267 101.019 706.366
201609 414.617 101.138 547.534
201612 252.808 102.022 330.960
201703 122.042 102.022 159.770
201706 173.854 102.752 225.980
201709 122.354 103.279 158.228
201712 87.336 103.793 112.384
201803 70.839 103.962 91.007
201806 68.115 104.875 86.746
201809 47.139 105.679 59.576
201812 -3.716 105.912 -4.686
201903 16.305 105.886 20.566
201906 17.583 106.742 22.001
201909 14.679 107.214 18.286
201912 13.667 107.766 16.938
202003 13.066 106.563 16.376
202006 10.415 107.498 12.940
202009 4.600 107.635 5.708
202012 17.939 108.296 22.124
202103 14.951 108.360 18.428
202106 12.355 108.928 15.149
202109 4.654 110.338 5.633
202112 24.567 112.486 29.170
202203 21.941 114.825 25.521
202206 19.027 118.384 21.466
202209 14.522 122.296 15.860
202212 16.904 126.365 17.866
202303 13.136 127.042 13.810
202306 10.071 129.407 10.394
202309 7.923 130.224 8.126
202312 6.360 131.912 6.439
202403 5.055 132.205 5.107
202406 6.186 132.716 6.225
202409 5.034 132.304 5.082
202412 2.961 132.987 2.974
202503 4.467 132.825 4.492
202506 3.986 133.699 3.982
202509 2.759 133.480 2.761
202512 2.015 133.390 2.018
202603 1.812 133.560 1.812

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr70.78 mean?
Guard Therapeutics International AB (OSTO:GUARD) has a Cyclically Adjusted Book per Share of kr70.78 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Guard Therapeutics International AB and its competitors.
Is Guard Therapeutics International AB's Cyclically Adjusted Book per Share too high?
Guard Therapeutics International AB's current Cyclically Adjusted Book per Share is kr70.78. Overall, Guard Therapeutics International AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Guard Therapeutics International AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Guard Therapeutics International AB's Cyclically Adjusted Book per Share of kr70.78 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Guard Therapeutics International AB and its competitors. Guard Therapeutics International AB's current Cyclically Adjusted Book per Share is kr70.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guard Therapeutics International AB stock overvalued right now?
Guard Therapeutics International AB (OSTO:GUARD) has a current Cyclically Adjusted Book per Share of kr70.78. The current Cyclically Adjusted Book per Share is kr70.78. Guard Therapeutics International AB's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Guard Therapeutics International AB (OSTO:GUARD), the current Cyclically Adjusted Book per Share is kr70.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guard Therapeutics International AB Business Description

Address Scheelevagen 22, Lund, SWE, 223 63
Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful treatment of acute kidney injuries.
25GF Score

Get the complete analysis for OSTO:GUARD

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.58
Price